What’s more, patients in the SOX11 altered group had shorter DSS and PFS than patients in the SOX11 unaltered group, suggesting that SOX11 gene alterations, particularly high mRNA levels, were risk factors for prognosis in breast cancer. Here, SOX11 is linked to breast cancer.